A detailed history of Dimensional Fund Advisors LP transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 604,041 shares of ALDX stock, worth $2.89 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
604,041
Previous 672,057 10.12%
Holding current value
$2.89 Million
Previous $2.22 Million 46.36%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$3.19 - $6.32 $216,971 - $429,861
-68,016 Reduced 10.12%
604,041 $3.26 Million
Q2 2024

Aug 09, 2024

SELL
$3.25 - $4.72 $682,997 - $991,922
-210,153 Reduced 23.82%
672,057 $2.22 Million
Q1 2024

May 10, 2024

SELL
$2.77 - $4.22 $433,344 - $660,185
-156,442 Reduced 15.06%
882,210 $2.88 Million
Q4 2023

Feb 07, 2024

SELL
$1.47 - $6.06 $244,566 - $1.01 Million
-166,372 Reduced 13.81%
1,038,652 $3.65 Million
Q3 2023

Nov 09, 2023

BUY
$6.11 - $8.16 $485,005 - $647,732
79,379 Added 7.05%
1,205,024 $8.05 Million
Q2 2023

Aug 09, 2023

BUY
$7.11 - $11.89 $19,460 - $32,542
2,737 Added 0.24%
1,125,645 $9.44 Million
Q1 2023

May 12, 2023

BUY
$5.77 - $9.93 $1.34 Million - $2.31 Million
232,676 Added 26.14%
1,122,908 $11.2 Million
Q4 2022

Feb 09, 2023

BUY
$5.08 - $7.09 $1.07 Million - $1.49 Million
210,219 Added 30.91%
890,232 $6.2 Million
Q3 2022

Nov 10, 2022

BUY
$3.8 - $7.74 $2.27 Million - $4.62 Million
597,093 Added 720.08%
680,013 $3.63 Million
Q2 2022

Aug 12, 2022

SELL
$2.43 - $4.85 $205,818 - $410,790
-84,699 Reduced 50.53%
82,920 $331,000
Q1 2022

May 13, 2022

SELL
$3.25 - $5.17 $298,996 - $475,634
-91,999 Reduced 35.44%
167,619 $745,000
Q4 2021

Feb 09, 2022

SELL
$3.5 - $9.63 $41,181 - $113,306
-11,766 Reduced 4.34%
259,618 $1.04 Million
Q2 2021

Aug 12, 2021

SELL
$10.44 - $14.85 $36,028 - $51,247
-3,451 Reduced 1.26%
271,384 $3.08 Million
Q1 2021

May 14, 2021

BUY
$6.53 - $14.42 $44,423 - $98,099
6,803 Added 2.54%
274,835 $3.27 Million
Q4 2020

Feb 25, 2021

BUY
$6.31 - $8.13 $1.69 Million - $2.18 Million
268,032 New
268,032 $1.84 Million

Others Institutions Holding ALDX

About Aldeyra Therapeutics, Inc.


  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $279M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.